Oral med for obesity, stem cells after heart failure, blood markers and MS, and predicting atherosclerosis

Program notes:0:37 An oral med for obesity1:37 Five to 10% stopped medication2:35 Need head-to-head trials with injectable3:00 Stem cell infusion after MI and heart failure4:01 Reduced heart failure in recipients5:01 Twice as many in the control arm6:01 Moving past BMI in predicting atherosclerosis7:01 Especially in overweight but not obese8:01 Almost 3000 participants in Brazil8:25 Blood samples precede MS9:04 Seen seven years beforehand10:02 Twin studies and relatives11:03 Way to intervene earlier11:15 Applaud OpenAI13:00 End